SEC Form 4 · accession 0001209191-18-058335
SUTRO BIOPHARMA, INC. · STRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shalini Sharp
Director
Period of report
Nov 8, 2018
Accepted (ET)
Nov 13, 2018 · 5:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001382101
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock)F1 | $14.23 | Nov 8, 2018 | A | 26,033 | A | — | Nov 7, 2028 | Common Stock | 26,033 | 26,033 | D |
Explanation of responses
- F1The option vests as to 2.777% of the total shares monthly, beginning on December 7, 2018, with 100% of the total shares vested and exercisable on November 7, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.